scispace - formally typeset
Open AccessJournal Article

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

Detection
- 01 Jan 1997 - 
- Vol. 157, pp 2413-2446
Reads0
Chats0
About
This article is published in JAMA Internal Medicine.The article was published on 1997-01-01 and is currently open access. It has received 5537 citations till now.

read more

Citations
More filters
Journal ArticleDOI

Second manifestations of ARTerial disease (SMART) study: rationale and design.

TL;DR: The Second Manifestations of ARTerial disease (SMART) study is a single-centre prospective cohort study among patients, newly referred to the hospital with clinically manifest atherosclerotic vessel disease, or marked risk factors for atherosclerosis to determine the prevalence of concomitant arterial disease at other sites, and risk factors in patients presenting with a manifestation of arterials disease or vascular risk factor.
Journal ArticleDOI

Impact of Diabetes on Cardiovascular Disease: An Update

TL;DR: The association between poor glycemic control, oxidative stress, markers of insulin resistance, and of low-grade inflammation that have been suggested as putative factors linking diabetes and cardiovascular disease are described.
Journal ArticleDOI

Serum Carboxy-Terminal Propeptide of Procollagen Type I Is a Marker of Myocardial Fibrosis in Hypertensive Heart Disease

TL;DR: Findings suggest that the determination of PIP may be an easy and reliable method for the screening and diagnosis of severe myocardial fibrosis associated with arterial hypertension.
Journal ArticleDOI

Insulin Resistance as an Independent Predictor of Cardiovascular Mortality in Patients with End-Stage Renal Disease

TL;DR: It is indicated that insulin resistance is an independent predictor of cardiovascular mortality in ESRD and the effect of HOMA-IR on cardiovascular mortality was independent of body mass index, hypertension, and dyslipidemia.
Journal ArticleDOI

Independent and Additive Impact of Blood Pressure Control and Angiotensin II Receptor Blockade on Renal Outcomes in the Irbesartan Diabetic Nephropathy Trial: Clinical Implications and Limitations

TL;DR: A SBP target between 120 and 130 mmHg is recommended, in conjunction with blockade of the renin-angiotensin system, in patients with type 2 diabetic nephropathy, and Progressive lowering of SBP to 120mmHg was associated with improved renal and patient survival, an effect independent of baseline renal function.
Related Papers (5)

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

M R Stearne, +262 more
- 12 Sep 1998 -